BackComera Life Sciences Holdings- Warrants (19/05/2027) Overview

Comera Life Sciences Holdings- Warrants (19/05/2027) Profit Margin

Valuation check: CMRAW's profit margin is -8421.91%, below the sector sector average of 13.09%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

-1580.01%
↓ 2.58% YoY

As of Sep 2023

Annual Profit Margin (TTM)

-8421.91%
↓ 100.24% YoY

Trailing 12 months ending Sep 2023

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Comera Life Sciences Holdings- Warrants (19/05/2027) (CMRAW) FAQ

Comera Life Sciences Holdings- Warrants (19/05/2027)'s profit margin stands at -8421.91% as of September 2023. That compares with -4205.98% in the prior-year period — down 100.2% year over year. That is below the sector sector average of 13.09%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Comera Life Sciences Holdings- Warrants (19/05/2027) reported -8421.91% in profit margin versus -4205.98% a year earlier — a 100.2% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

Comera Life Sciences Holdings- Warrants (19/05/2027) sits lower the its sector benchmark (13.09%) with a profit margin of -8421.91%. That is roughly 64445.8% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of -8421.91% for Comera Life Sciences Holdings- Warrants (19/05/2027) means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Comera Life Sciences Holdings- Warrants (19/05/2027)'s profit margin evolved across reporting periods, while the comparison chart places CMRAW next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.